By API User
Dr Aeson Chang from Monash University has been awarded 2025 Gilead Sciences Research Scholars Program grant Dr Chang becomes one of only three researchers globally to receive the 2025 grant in the Solid Tumours category Two-year funding will support research exploring the potential role of a common anti-nausea medication in improving breast cancer outcomes, following … Continued
By API User
Brandon BioCatalyst’s CUREator set to support up to 15 therapeutic biotechs thanks to funding from the Medical Research Future Fund Melbourne, Wednesday 16 July: Brandon BioCatalyst’s national biotech incubator, CUREator, is set to deliver a program with support from CSIRO that will assist Australian biotechs developing novel therapeutics across the preclinical and clinical stages … Continued
By API User
Partnership established to develop and scale production of ATL-105, a novel recombinant version of alpha-1 antitrypsin Lead indication is non-CF bronchiectasis; ATL-105 targets disease drivers through a broad multimodal mechanism of action VILNIUS, LT / ACCESS Newswire / July 15, 2025 / AATec Medical GmbH (“AATec”), a biotech company developing a multi-product platform for the … Continued
By API User
Pancreatic cancer treatment device company OncoSil Medical Limited (ASX:OSL) is pleased to announce the appointment of Dr Thomas Duthy as a Non-Executive Director, effective 11 July 2025. Dr Duthy brings more than 21 years of experience across financial markets, corporate development, and board-level roles in the healthcare and life sciences sectors. He was previously Head … Continued
By API User
BlinkLab Limited (ASX:BB1) (“BlinkLab” or “the Company”) is pleased to announce the expansion of its U.S. clinical trial network with the University of Nebraska Medical Center (UNMC) engaged as the second site in the main phase of its FDA 510(k) study for BlinkLab Dx 1 – its smartphone-based diagnostic tool for early autism detection. Highlights … Continued
By API User
Call continues for Australian submissions to “Go Healthy with Taiwan” 8 July 2025: The Taiwan Trade Centre in Sydney is continuing to encourage Australian health innovators, companies, entrepreneurs and researchers to make submissions to its “Go Healthy with Taiwan” campaign. The deadline for submissions is August 14, with six finalists being flown to Taiwan to … Continued
By API User
Highlights: Patient recruitment for the PANCOSIL trial has now been successfully completed. This trial is an important part of OncoSil Medical’s well-articulated clinical development strategy. The primary objective of the PANCOSIL trial is to assess a novel delivery method for the OncoSil™ device via a CT-guided percutaneous approach. OncoSil Medical expects preliminary data from the PANCOSIL study to … Continued
By API User
30 June 2025 – Perth, Australia | BlinkLab Limited (ASX:BB1), a digital health company developing AI-powered smartphone-based diagnostic technology for autism and ADHD, is pleased to announce that it has received Institutional Review Board (IRB) ethics approval from the WIRB-Copernicus Group (WCG) for commencing the main phase of its United States FDA 510(k) clinical trial … Continued
By API User
This introduction brings one of the world’s most advanced exosome technologies to New Zealand, with two exclusive events set to take place in: • Auckland – July 15, 2025 | The Boathouse, Park Hyatt Auckland, from 6:30pm • Christchurch – July 17, 2025 | Chateau on the Park, DoubleTree by Hilton, from 6:30pm These … Continued
By API User
BUFFALO, NEW YORK / ACCESS Newswire / June 23, 2025 / ZeptoMetrix® is pleased to announce the launch of NATtrol™ Influenza A H5N1 Quantitative Stock, a groundbreaking advancement in molecular diagnostic quality assurance. Leveraging phage-like particle encapsulated RNA technology, this product sets a new standard for accuracy and reliability in avian influenza (H5N1) detection, addressing … Continued
